文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

美国胃肠道恶性肿瘤机器人手术趋势与围术期及肿瘤学安全结局

Trends and outcomes of robotic surgery for gastrointestinal (GI) cancers in the USA: maintaining perioperative and oncologic safety.
PubMed 文献 · Surg Endosc · 2019-12-09

该研究基于美国国家癌症数据库(2010–2014),分析食管、胃、胰腺、结肠、直肠癌切除的微创与开放手术趋势及结局。机器人切除在各器官部位增长近四倍,围术期结局与肿瘤学安全未见受损。

要点

  • 机器人胃肠癌切除2010至2014年增长近四倍,开放手术减少。
  • 机器人组住院更短、90天再入院和死亡率更低(直肠切除再入院除外)。
  • 机器人组切缘阴性和淋巴结数量与腹腔镜及开放手术相当。

核心结论

  • 胃肠道恶性肿瘤机器人辅助切除使用快速增加,围术期结局和肿瘤学安全未受损。

研究设计与样本

  • 回顾性队列研究,使用美国国家癌症数据库2010–2014年数据。
  • 纳入食管11023例、胃30664例、胰腺30689例、结肠260669例、直肠52239例切除患者。
  • 比较机器人、腹腔镜与开放手术的围术期结局和病理质量,采用多水平logistic回归模型。

主要发现

  • 机器人切除在各器官部位增长近四倍:食管3.8倍、胃4.4倍、胰腺4.4倍、结肠3.8倍、直肠4倍。
  • 腹腔镜切除增长较慢(1.3–1.9倍),开放切除减少(0.67–0.77倍)。
  • 机器人组胃和结直肠切除患者更年轻,所有部位Charlson合并症指数更低。
  • 机器人和腹腔镜组住院更短、90天术后死亡率更低;再入院更少(直肠切除除外)。
  • 机器人组切缘阴性和淋巴结数量与腹腔镜及开放手术相当。

临床怎么用

  • 机器人胃肠癌切除在年轻健康患者中应用增多,围术期和肿瘤学结局与腹腔镜及开放手术相当。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Minimally invasive surgery (MIS) continues to gain traction as a feasible approach for the operative management of gastrointestinal (GI) malignancies. The aim of this study is to quantify national trends, perioperative and oncologic outcomes of MIS for the most common GI malignancies including the esophagus, stomach, pancreas, colon, and rectum. We hypothesize that with more widespread use of MIS techniques, perioperative outcomes and oncologic resection quality will remain preserved. METHODS: The National Cancer Database (2010-2014) was utilized to assess perioperative outcomes and pathologic quality of MIS (robotic and laparoscopic) compared to open, in patients who underwent resection for cancers of the esophagus, stomach, pancreas, colon, and rectum. Multilevel logistic regression models were constructed to identify independent factors associated with postoperative and long-term outcomes. RESULTS: Data from 11,023 esophageal, 30,664 gastric, 30,689 pancreas, 260,669 colon, and 52,239 rectal resections were analyzed. Although laparoscopy is the most prevalent MIS approach, the number of robotic resections increased nearly fourfold from 2010 to 2014 in all organ sites (increase by factor: esophagus: 3.8, stomach: 4.4, pancreas: 4.4, colon: 3.8 and rectum: 4). The number of laparoscopic resections increased at a slower rate (factor: 1.3-1.9), whereas the number of open resections decreased (factor: 0.67-0.77). Patients who underwent robotic-assisted resections were younger for stomach and colorectal resections and with lower Charlson Comorbidity Index across all sites. Patients who underwent robotic or laparoscopic resections had shorter hospitalizations, fewer readmissions (with the exception of rectal resections) and lower postoperative mortality at 90 days. Robotic-assisted resections had comparable negative margin resections and number of lymph nodes to laparoscopic and open resections across all sites. CONCLUSION: The utilization of robotic-assisted resections of GI cancers is rapidly increasing with more frequent use in younger and healthier patients. This study demonstrates that with the rising utilization of robotic-assisted resections, perioperative outcomes and oncologic safety have not been compromised.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Konstantinidis IT, Ituarte P, Woo Y, et al. Trends and outcomes of robotic surgery for gastrointestinal (GI) cancers in the USA: maintaining perioperative and oncologic safety. Surg Endosc. 2019. PMID: 31820161. doi:10.1007/s00464-019-07284-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。